妖精视频在线观看免费播放电视剧,SONE-367本乡爱在线观看,华丽的外出视频

WCK-5153

NMR下載 COA and HPLC MSDS下載
names：
(2S,5R)-7-oxo-2-(2-((S)-pyrrolidine-3-carbonyl)hydrazine-1-carbonyl)-1,6-diazabicyclo[3.2.1]octan-6-yl hydrogen sulfate
CAS號(hào)：
1436862-38-2
MDL Number：
MF(分子式)： C12H19N5O7S MW(分子量)： 377.372
EINECS: Reaxys Number:
Pubchem ID: Brand:BIOFOUNT

貨品編碼	規(guī)格	純度	價(jià)格 (￥)	現(xiàn)價(jià)(￥)	特價(jià)(￥)	庫(kù)存描述	數(shù)量	總計(jì) (￥)

大包裝詢價(jià) 提供各種包裝，敬請(qǐng)垂詢
收藏商品商品點(diǎn)評(píng) 加入購(gòu)物車立即購(gòu)買

快速詢價(jià)

收起

你想詢價(jià)的產(chǎn)品

*產(chǎn)品名稱：

CAS號(hào)：

產(chǎn)品編號(hào)：

需求描述：

請(qǐng)準(zhǔn)確填寫您的聯(lián)系方式，以便為您提供最好的服務(wù)。

*公司名稱：

*電子郵箱：

聯(lián)系人：

*電話：

*驗(yàn)證碼：

詢價(jià)

中文別名	(2S,5R)-7-oxo-2-(2-((S)-pyrrolidine-3-carbonyl)hydrazine-1-carbonyl)-1,6-diazabicyclo[3.2.1]octan-6-yl hydrogen sulfate
英文別名	WCK-5153; WCK 5153; WCK5153.
CAS號(hào)	1436862-38-2
Inchi	InChI=1S/C12H19N5O7S/c18-10(7-3-4-13-5-7)14-15-11(19)9-2-1-8-6-16(9)12(20)17(8)24-25(21,22)23/h7-9,13H,1-6H2,(H,14,18)(H,15,19)(H,21,22,23)/t7-,8+,9-/m0/s1
InchiKey	NAURQUDBIPQVFZ-YIZRAAEISA-N
分子式 Formula	C12H19N5O7S
分子量 Molecular Weight	377.372
溶解度Solubility
性狀	Solid powder
儲(chǔ)藏條件 Storage conditions	Dry, dark and store at 0-4℃ for short term (days to weeks) or -20℃ for long term (Store correctly 2-3years).

產(chǎn)品說(shuō)明	WCK-5153(CAS:1436862-38-2):僅限應(yīng)用于工業(yè)或者科學(xué)研究過(guò)程中非醫(yī)療目的，不應(yīng)用于人類或動(dòng)物的臨床診斷以及治過(guò)程療，該產(chǎn)品非藥用，非食用。
Introduction	WCK-5153 is a Novel Inhibitor of PBP2 Showing Potent "β-Lactam Enhancer" Activity against Pseudomonas aeruginosa, Including Multidrug-Resistant Metallo-β-Lactamase-Producing High-Risk Clones. WCK 5153 demonstrated specific high-affinity binding to PBP2 of A. baumannii. WCK 5153 shows a potent β-lactam enhancer effect against A. baumannii, including a multidrug-resistant OXA-23-producing ST2 international clone.
Application1
Application2
Application3

警示圖
危險(xiǎn)性	Warning
危險(xiǎn)性警示
安全聲明
安全防護(hù)
備注

[1]Papp-Wallace KM, Nguyen NQ, Jacobs MR, Bethel CR, Barnes MD, Kumar V,Bajaksouzian S, Rudin SD, Rather PN, Bhavsar S, Ravikumar T, Deshpande PK, PatilV, Yeole R, Bhagwat SS, Patel MV, van den Akker F, Bonomo RA. Strategicapproaches to overcome resistance against Gram negative pathogens usingβ-lactamase inhibitors and β-lactam enhancers: The activity of three noveldiazabicyclooctanes, WCK 5153, zidebactam (WCK 5107), and WCK 4234. J Med Chem.2018 Apr 7. doi: 10.1021/acs.jmedchem.8b0009[1][Epub ahead of print] PubMed PMID:29627985.

[2]Moya B, Barcelo IM, Bhagwat S, Patel M, Bou G, Papp-Wallace KM, Bonomo RA,Oliver A. Potent β-Lactam Enhancer Activity of Zidebactam and WCK 5153 againstAcinetobacter baumannii, Including Carbapenemase-Producing Clinical Isolates.Antimicrob Agents Chemother. 2017 Oct 24;61(11). pii: e01238-17. doi:10.1128/AAC.01238-17. Print 2017 Nov. PubMed PMID: 28848013; PubMed CentralPMCID: PMC5655067.

[3] Moya B, Barcelo IM, Bhagwat S, Patel M, Bou G, Papp-Wallace KM, Bonomo RA,Oliver A. WCK 5107 (Zidebactam) and WCK 5153 Are Novel Inhibitors of PBP2 ShowingPotent "β-Lactam Enhancer" Activity against Pseudomonas aeruginosa, IncludingMultidrug-Resistant Metallo-β-Lactamase-Producing High-Risk Clones. AntimicrobAgents Chemother. 2017 May 24;61(6). pii: e02529-16. doi: 10.1128/AAC.02529-16.Print 2017 Jun. PubMed PMID: 28289035; PubMed Central PMCID: PMC5444176.

對(duì)不起，暫無(wú)產(chǎn)品評(píng)價(jià)！

MSDS

SDS 1.0 中文

展開

SDS 1.0 英文

展開